Bausch + Lomb Corporation (TSX:BLCO)
28.30
-1.40 (-4.71%)
Nov 20, 2026, 12:00 PM EST
Bausch + Lomb Employees
Bausch + Lomb had 13,000 employees as of December 31, 2025. The number of employees decreased by 500 or 3.70% compared to the previous year.
Employees
13,000
Change (1Y)
-500
Growth (1Y)
-3.70%
Revenue / Employee
591.67K CAD
Profits / Employee
-12.12K CAD
Market Cap
10.09B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13,000 | -500 | -3.70% |
| Dec 31, 2024 | 13,500 | 200 | 1.50% |
| Dec 31, 2023 | 13,300 | 400 | 3.10% |
| Dec 31, 2022 | 12,900 | 400 | 3.20% |
| Dec 31, 2021 | 12,500 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 5,000 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Vireo Growth | 612 |
Bausch + Lomb News
- 19 hours ago - Bausch + Lomb Transcript: Study result - Transcripts
- 19 hours ago - Bausch + Lomb Press release: Study result - Filings
- 19 hours ago - Bausch + Lomb Slides: Study result - Filings
- 19 hours ago - Bausch + Lomb eye-drop drug misses mid-stage study main goal - Reuters
- 20 hours ago - Bausch + Lomb says Phase 2 BL1332 study does not meet primary endpoint - TheFly
- 3 days ago - Bausch + Lomb price target raised to $27 from $24 at Barclays - TheFly
- 18 days ago - Bausch + Lomb downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 22 days ago - Bausch + Lomb price target raised to $20 from $16 at Deutsche Bank - TheFly